Johnson & Johnson announced today that it received FDA de novo authorization for its Ottava surgical robot system.

Johnson & Johnson, the giant pharmaceutical company best known for its Tylenol and Band-Aid brands, on Thursday said it has picked Tampa as its headquarters to house key ...

Johnson & Johnson, in a motion for order to show cause, insisted that lead plaintiffs’ counsel in the talc multidistrict ...

Johnson & Johnson JNJ on Wednesday reported second-quarter 2026 results that topped Wall Street estimates and raised its full ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Nearly six years after unveiling its Ottava robotics platform, Johnson & Johnson (NYSE:JNJ) has finally cleared a major ...

JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies ...

In Wednesday's order, U.S. Magistrate Judge Rukhsanah Singh, in the District of New Jersey, raised "deep skepticism" about ...

Johnson & Johnson offers a combination of an AAA-tier balance sheet, a 64-consecutive year dividend growth streak and a ...

The drug and medical-device maker raised its forecast for the year after recording higher sales in the second quarter.

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Thursday told investors why he thinks the stock of Johnson & Johnson is performing well this year even as the broader healthcare sector lags.